Pfizer's deliberations, which previously have not been disclosed, offer a rare window into the frustrating search for Alzheimer's treatments inside one of the world's largest drug companies. Despite ...
In a scant notice posted to its website on Wednesday, the European Medicines Agency (EMA) divulged that it has been hit by a cyberattack. While the agency did not reveal any details about the extent ...
Regulatory Recon: Pfizer Weighs Sale of Consumer Health Business FDA Releases Briefing Documents for Spark Gene Therapy (10 October 2017) Welcome to Regulatory Reconnaissance, your daily regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results